{
    "organizations": [],
    "uuid": "e8c76cba28729142d9b1ad2e72944c62166035e7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/us-ablynx-m-a-sanofi-suspension/ablynx-shares-suspended-after-sanofi-bid-regulator-idUSKBN1FI0O3",
    "ord_in_thread": 0,
    "title": "Ablynx shares suspended after Sanofi bid - regulator",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BRUSSELS (Reuters) - Shares of Belgian biotech group Ablynx ( ABLX.BR ) will be suspended until 1030 local time (0930 GMT), following a 45 euros epr share bid by French pharma group Sanofi ( SASY.PA ), the Belgian market regulator said.\nThe shares were suspended to allow an “adequate dissemination of a press release”, the regulator said in a statement.\nReporting by Robert-Jan Bartunek; editing by Philip Blenkinsop\n ",
    "published": "2018-01-29T15:42:00.000+02:00",
    "crawled": "2018-01-29T15:05:29.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "brussels",
        "reuters",
        "share",
        "belgian",
        "biotech",
        "group",
        "ablynx",
        "suspended",
        "local",
        "time",
        "gmt",
        "following",
        "euro",
        "epr",
        "share",
        "bid",
        "french",
        "pharma",
        "group",
        "sanofi",
        "belgian",
        "market",
        "regulator",
        "said",
        "share",
        "suspended",
        "allow",
        "adequate",
        "dissemination",
        "press",
        "release",
        "regulator",
        "said",
        "statement",
        "reporting",
        "bartunek",
        "editing",
        "philip",
        "blenkinsop"
    ]
}